This high level of M&A activity is unusual for the early part of the year, with pharmaceuticals accounting for the bulk of very large deals completed so far. There is a prevailing trend of outperformance for acquirers and consistency across sectors, with acquirers in general outperforming their industry peers.
- Steve Allan, M&A Practice Leader (EMEA)
Insurers have plenty to keep them up at night, but as a panel of Towers Watson experts explains, there's no need to lose sleep if companies are forward thinking and strategic.
2015 Americas HR Service Delivery and Technology Forum
Learn more and register
Global Financial Services Conference
You must be logged in to access this feature.